Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

H. M. Westgeest; M. Kuppen; A. J.M. van den Eertwegh; J. Van Moorselaar; N. Mehra; I. van Oort; A. C.M. van den Bergh; J. L. Coenen; K. K.H. Aben; R. Somford; R. de Wit; A. Bergman; J. Lavalaye; C. A. Uyl-de Groot; W. R. Gerritsen

doi:https://doi.org/10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

H. M. Westgeest, M. Kuppen, A. J.M. van den Eertwegh, J. Van Moorselaar, N. Mehra, I. van Oort, A. C.M. van den Bergh, J. L. Coenen, K. K.H. Aben, R. Somford, R. de Wit, A. Bergman, J. Lavalaye, C. A. Uyl-de Groot, W. R. Gerritsen

Research output: Contribution to journal › Article › Academic › peer-review

42 Citations (Scopus)

Original language	English
Pages (from-to)	viii283-viii284
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy284.026
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy284.026

Cite this

Westgeest, H. M., Kuppen, M., van den Eertwegh, A. J. M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A. C. M., Coenen, J. L., Aben, K. K. H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C. A., & Gerritsen, W. R. (2018). Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii283-viii284. https://doi.org/10.1093/annonc/mdy284.026

@article{b24b6732c80b4a7ba396baccd913462c,

title = "Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands",

author = "Westgeest, {H. M.} and M. Kuppen and {van den Eertwegh}, {A. J.M.} and {Van Moorselaar}, J. and N. Mehra and {van Oort}, I. and {van den Bergh}, {A. C.M.} and Coenen, {J. L.} and Aben, {K. K.H.} and R. Somford and {de Wit}, R. and A. Bergman and J. Lavalaye and {Uyl-de Groot}, {C. A.} and Gerritsen, {W. R.}",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy284.026",

language = "English",

volume = "29",

pages = "viii283--viii284",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Westgeest, HM, Kuppen, M, van den Eertwegh, AJM , Van Moorselaar, J, Mehra, N, van Oort, I, van den Bergh, ACM, Coenen, JL, Aben, KKH, Somford, R, de Wit, R, Bergman, A, Lavalaye, J, Uyl-de Groot, CA & Gerritsen, WR 2018, 'Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii283-viii284. https://doi.org/10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. / Westgeest, H. M.; Kuppen, M.; van den Eertwegh, A. J.M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii283-viii284.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI

T2 - An observational study in the Netherlands

AU - Westgeest, H. M.

AU - Kuppen, M.

AU - van den Eertwegh, A. J.M.

AU - Van Moorselaar, J.

AU - Mehra, N.

AU - van Oort, I.

AU - van den Bergh, A. C.M.

AU - Coenen, J. L.

AU - Aben, K. K.H.

AU - Somford, R.

AU - de Wit, R.

AU - Bergman, A.

AU - Lavalaye, J.

AU - Uyl-de Groot, C. A.

AU - Gerritsen, W. R.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531692&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy284.026

DO - https://doi.org/10.1093/annonc/mdy284.026

M3 - Article

C2 - 32136651

SN - 0923-7534

VL - 29

SP - viii283-viii284

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Westgeest HM, Kuppen M, van den Eertwegh AJM , Van Moorselaar J, Mehra N, van Oort I et al. Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii283-viii284. doi: https://doi.org/10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

Access to Document

Other files and links

Cite this